Abstract
A cancer registry is an organization set up for the collection, storage, analysis, and interpretation of data on people with cancer. There are three types of cancer registry: hospital-based, population-based, and nationwide site-specific. A cancer registry is essential for planning and evaluating cancer control activities, including clinical practices. We describe the significance and usefulness of cancer registries, with examples of assessments of the size of the cancer problem (i.e., incidence, mortality rates, and survival of cancer patients), assessments of the effects of cancer control programs, feedback to clinicians, and the building and testing of hypotheses of cancer etiology.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Parkin DM, Wagner G, Muirc (eds) (1985) The role of the registry in cancer control. International Agency for Research on Cancer (IARC) Scientific Publications No. 66. IARC, Lyon
Parkin DM, Whelan SL, Ferlay J, et al. (1997) Cancer incidence in five continents. Vol. VII. International Agency for Research on Cancer Scientific Publications No. 143. IARC, Lyon
Oshima A (ed) (1998) Survey of population-based cancer registries in Japan in 1997 (in Japanese). Japan Public Health Association, Tokyo
Fujimoto I, Hanai A, Hiyama T, et al. (eds) Cancer incidence and mortality in Osaka 1963–1989 (1993) Osaka Foundation for Prevention of Cancer and Circulatory Diseases, Osaka
Oshima A, Tsukuma H, Ajiki W, et al. (eds) (1998) Survival of cancer patients in Osaka 1975–89. Osaka Foundation for Prevention of Cancer and Circulatory Diseases, Osaka
Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985–89 (1998) Re-estimation based on data from eight cancer registries. Jpn J Clin Oncol 28:54–67
Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan in 1992–1993 (1998) Estimates based on data from population-based cancer registries. Jpn J Clin Oncol 28:641–647
Fujimoto I, Hanai A, Tominaga S, Kuroishi T (1988) Future predictions of cancer incidence in Japan (in Japanese). Jpn J Cancer Clin 34:1911–1916
Tsukuma H, Kitagawa T, Hanai A, et al. (1992) Incidence of cancer predictions in Japan up to the year 2015 (in Japanese with English abstract). Jpn J Cancer Clin 38:1–10
Kitagawa T, Tsukuma H, Kuroishi T, Hanai A (1996) Future prediction of cancer incidence in Japan based on the incidence data 1975-89 (in Japanese). Kosei no Shihyo (Indices of Health and Welfare) 43:10–18
Ajiki W, Tsukuma H, Oshima A (1998) Time trends of survival for patients with stomach, lung and breast cancers, and factors attributed to their improvement. Jpn J Cancer Res 89 (Suppl); 253
Woods WG, Tuchman M, Robison LL, et al. (1996) A populationbased study of the usefulness of screening for neuroblastoma. Lancet 384:1682–1687
Ajiki W, Tsukuma H, Oshima A (1998) Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes Control (in press)
Oshima A, Sakagami F, Hanai A, Fujimoto I (1979) A method of record linkage. Environ Health Perspect 32:537–546
Murakami R, Tsukuma H, Ubukata T, et al. (1990) Estimation of validity of mass screening program for gastric cancer in Osaka, Japan. Cancer 65:1255–1260
Sobue T, Suzuki T, Matsuda M (1991) Sensitivity and specificity of lung cancer screening in Osaka, Japan. Jpn J Cancer Res 82:1069–1076
Fujita M, Okayama Y, Murakami R, et al. (1995) Sensitivity, specificity, and positive predictivity of the immunological fecal occult blood test (RPHA) in mass screening for colorectal cancers (in Japanese). J Gastroenterol Mass Survey 33:477–485
Murakami R, Tsukuma H, Kanamori S, et al. (1990) Natural history of colorectal polyps and the effect of polypectomy on occurrence of subsequent cancer. Int J Cancer 46:159–164
Imai Y, Kawata S, Tamura S, et al. (1998) Relation of interferon therapy for hepatocellular carcinoma in patients with chronic hepatitis C. Ann Intern Med 129:94–99
Oshima A, Tsukuma H, Hiyama T, et al. (1984) Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 34:775–779
Tatsuta M, Iishi H, Nakaizumi A, et al. (1993) Fundal atrophic gusfritis as a risk factor for gastric cancer. Int J Cancer 53:70–74
Kawashima T (1991) Epidemiological study on the risk of gastric cancer for patients with duodenal ulcer (in Japanese with English abstract). Jpn J Gastroenterol 88:1161–1167
Hiyama T, Fujimoto I, Hanai A (1985) Occurrence of second primary cancers among patients with cervical cancer in Osaka, Japan. Natl Cancer Inst Monogr 69:181–184
Fujimoto I, Hanai A, Murakami R, Yoshitake J (1985) Association of second primary leukemias with the method of treatment of the first primary cancer. Jpn J Clin Oncol 15 Suppl 1):265–270
Murakami R, Hiyama T, Hanai A, Fujimoto I (1987) Second primary cancers following female breast cancer in Osaka, Japan. A population-based cohort study. Jpn J Clin Oncl 17:293–302
Hiyama T, Hanai A, Fujimoto I (1991) Second primary cancer after diagnosis of stomach cancer in Osaka, Japan. Jpn J Cancer Res 82:762–770
Tanaka H, Hiyama T, Hanai A, Fujimoto I (1991) Second primary cancers following colon and rectal cancer in Osaka, Japan. Jpn J Cancer Res 82:1356–1365
Tsukuma H, Fujimoto I, Hanai A, et al. (1994) Incidence of second primary cancers in Osaka residents, Japan with special reference to cumulative and relative risks. Jpn J Cancer Res 85:339–345
Greenwald P, Kramer BS, Weed DL (eds) (1995) Cancer prevention and control. Marcel Dekker, New York
Schottnfeld D, Fruumeni JP (eds) (1996) Cancer epidemiology and prevention., 2nd edn. Oxford University Press, New York
Tsukuma H (1996) Epidemiology. In: Ariyoshi H, Saijo N, Sasaki Y, Fukuoka M, Watanabe T (eds). Clinical oncology (in Japanese). Gan to Kagakuryohosha, Tokyo, chapter 13, pp 209–226
Okamoto N, Murata M, Sasaki T, et al. (1996) Five-year relative survival rates of patients with cancer at cancer center hospitals in Japan (in Japanese with English abstract). Jpn J Cancer Clin 42:1183–1188
Hiyama T, Sato T, Yoshino K, et al. (1992) Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res 83:334–339
Kinoshita N, Koyama Y, Yoshino K, et al. (1997) Second primary cancers occurring in patients with cancers of the mouth and mesohypo pharynx in Japan (in Japanese with English abstract). Jpn J Public Health 44:201–206
Ajiki W, Tsukuma H, Oshima A, Tanaka H (1997) Multiple primary cancer in patients with laryngeal cancer — effect of smoking habits after treatment (in Japanese). J Epidemiol 7 (Suppl): 86
Watanabe S, Tominaga S, Kakizoe T (eds) (1995) Cancer treatment and survival. Site-specific registries in Japan. Monograph on cancer research No. 43. Japan Scientific Societies Press Tokyo
The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. In: Watanabe S, Tominaga S, Kakizoe T (eds) (1995) Cancer treatment and survival. Site-specific registries in Japan. Japan Scientific Societies Press Tokyo, pp 81–95
Muir CS, Demaret E, Boyle P. The cancer registry in cancer control. Overview. In: Parkin DM, Wagner G, Muir C (eds) (1985) The role of the registry in cancer control. IARC, Lyon, chapter 2, pp 13–26
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Oshima, A., Ajiki, W., Tanaka, H. et al. Significance and usefulness of cancer registries. Int J Clin Oncol 3, 343–350 (1998). https://doi.org/10.1007/BF00539211
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00539211